Loading...
XETR
AAQ1
Market cap14mUSD
Dec 04, Last price  
1.36EUR
1D
0.00%
1Q
-17.58%
Jan 2017
-87.68%
Name

Aap Implantate AG

Chart & Performance

D1W1MN
XETR:AAQ1 chart
P/E
—
P/S
1.00
EPS
—
Div Yield, %
—
Shrs. gr., 5y
23.17%
Rev. gr., 5y
0.78%
Revenues
12m
+6.32%
14,250,000028,006,00031,884,00033,101,00028,440,00029,205,00036,414,00027,672,00030,414,00012,280,00010,486,00010,902,00010,781,00011,739,0009,326,00012,166,00011,516,00011,478,00012,203,000
Net income
-4m
L-29.17%
655,00001,511,000-5,234,0001,938,00051,000395,0002,410,000-2,454,000-456,000-5,292,00014,629,000-9,271,000-7,666,000-19,439,000-8,937,000-2,522,000-2,564,000-5,125,000-3,630,000
CFO
-1m
L-56.89%
718,0001,729,000-299,000544,0004,761,0002,654,0003,213,0007,088,0003,547,000-2,945,000-2,265,000-7,203,000-5,428,000-5,919,000-5,767,000-3,675,000-2,470,000-1,893,000-2,992,000-1,290,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

aap Implantate AG, a medical device company, develops, manufactures, and markets trauma products for orthopedics in Germany, the United States, and internationally. It offers LOQTEQ, an anatomical plating system for fracture treatment; and a range of cannulated screws, standard plates, and screws. The company sells its products directly to hospitals, buying syndicates, and hospital groups, as well as through a network of distributors under the aap brand name. aap Implantate AG was founded in 1990 and is headquartered in Berlin, Germany.
URL
https://www.aap.de/
IPO date
May 10, 1999
Employees
111
Domiciled in
DE
Incorporated in
DE

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT